|
61 |
Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2
Enthalten in Brain imaging and behavior 2.5.2016: 1-10
|
|
|
|
62 |
Erratum to: Dendritic cells as therapeutic targets in neuroinflammation
Enthalten in Cellular and molecular life sciences 22.4.2016: 1
|
|
|
|
63 |
Dendritic cells as therapeutic targets in neuroinflammation
Enthalten in Cellular and molecular life sciences 12.3.2016: 1-26
|
|
|
|
64 |
MAPK3 deficiency drives autoimmunity via DC arming
Enthalten in European journal of immunology Bd. 40, 2010, Nr. 5: 1486-1495. 10 S.
|
|
|
|
65 |
AAN unveils new guidelines for MS disease-modifying therapy
Enthalten in Nature reviews / Neurology Bd. 14, 12.6.2018, Nr. 7, date:7.2018: 384-386
|
|
|
|
66 |
Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex
Enthalten in European radiology Bd. 26, 22.10.2015, Nr. 8, date:8.2016: 2578-2586
|
|
|
|
67 |
Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study
Enthalten in Brain imaging and behavior Bd. 10, 9.11.2015, Nr. 4, date:12.2016: 1117-1126
|
|
|
|
68 |
Discriminative power of intra-retinal layers in early multiple sclerosis using 3D OCT imaging
Enthalten in Journal of neurology Bd. 265, 2.8.2018, Nr. 10, date:10.2018: 2284-2294
|
|
|
|
69 |
Disease reactivation after switching from natalizumab to daclizumab
Enthalten in Journal of neurology Bd. 264, 3.10.2017, Nr. 12, date:12.2017: 2491-2494
|
|
|
|
70 |
DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
Enthalten in Nature Communications Bd. 9, 19.6.2018, Nr. 1, date:12.2018: 1-15
|
|
Administration
